Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor
cells.
PURPOSE: This phase II trial is studying how well giving methotrexate and zidovudine together
with radiation therapy works in treating patients with HIV-related primary central nervous
system lymphoma.